» Articles » PMID: 28151918

Thalamic Pain Alleviated by Stellate Ganglion Block: A Case Report

Overview
Specialty General Medicine
Date 2017 Feb 3
PMID 28151918
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Thalamic pain is a distressing and treatment-resistant type of central post-stroke pain. Although stellate ganglion block is an established intervention used in pain management, its use in the treatment of thalamic pain has never been reported.

Patient Concerns: A 66-year-old woman presented with a 3-year history of severe intermittent lancinating pain on the right side of the face and the right hand. The pain started from the ulnar side of the right forearm after a mild ischemic stroke in bilateral basal ganglia and left thalamus. Weeks later, the pain extended to the dorsum of the finger tips and the whole palmar surface, becoming more severe. Meanwhile, there was also pain with similar characteristics emerging on her right face, resembling atypical trigeminal neuralgia.

Diagnoses: Thalamic pain was diagnosed.

Interventions: After refusing the further invasive treatment, she was suggested to try stellate ganglion block.

Outcomes: After a 3-day period of pain free (numerical rating scale: 0) postoperatively, she reported moderate to good pain relief with a numerical rating scale of about 3 to 4 lasting 1 month after the first injection. Pain as well as the quality of life was markedly improved with less dose of analgesic agents.

Lessons: Stellate ganglion block may be an optional treatment for thalamic pain.

Citing Articles

Stellate ganglion block beyond chronic pain: A literature review on its application in painful and non-painful conditions.

Singh H, Rajarathinam M J Anaesthesiol Clin Pharmacol. 2024; 40(2):185-191.

PMID: 38919437 PMC: 11196062. DOI: 10.4103/joacp.joacp_304_22.


Advances in the Treatment of Neuropathic Pain by Sympathetic Regulation.

Xu P, Fan H, Zhang E, Zhang H, Fei Y Curr Pain Headache Rep. 2024; 28(11):1167-1176.

PMID: 38907791 PMC: 11461765. DOI: 10.1007/s11916-024-01285-9.


Hyperbaric oxygen therapy for thalamic pain syndrome: case report.

Slade J, Kwan N, Lennox P, Gray R Front Neurol. 2024; 15:1364716.

PMID: 38545283 PMC: 10965551. DOI: 10.3389/fneur.2024.1364716.


Stellate ganglion block ameliorated central post-stroke pain with comorbid anxiety and depression through inhibiting HIF-1α/NLRP3 signaling following thalamic hemorrhagic stroke.

Shi Z, Jing J, Xue Z, Chen W, Tang Y, Chen D J Neuroinflammation. 2023; 20(1):82.

PMID: 36944982 PMC: 10031944. DOI: 10.1186/s12974-023-02765-2.


Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies.

Gurba K, Chaudhry R, Haroutounian S CNS Drugs. 2022; 36(5):483-516.

PMID: 35513603 DOI: 10.1007/s40263-022-00914-4.


References
1.
Woo A, Tharakan L, Vargulescu R . Stellate Ganglion Block for Painful Congenital Venous Malformation of the Arm. Pain Pract. 2015; 15(6):E65-8. DOI: 10.1111/papr.12296. View

2.
Kumar N, Thapa D, Gombar S, Ahuja V, Gupta R . Analgesic efficacy of pre-operative stellate ganglion block on postoperative pain relief: a randomised controlled trial. Anaesthesia. 2014; 69(9):954-660. DOI: 10.1111/anae.12774. View

3.
Klit H, Finnerup N, Jensen T . Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol. 2009; 8(9):857-68. DOI: 10.1016/S1474-4422(09)70176-0. View

4.
Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

5.
Vartiainen N, Perchet C, Magnin M, Creach C, Convers P, Nighoghossian N . Thalamic pain: anatomical and physiological indices of prediction. Brain. 2016; 139(Pt 3):708-22. DOI: 10.1093/brain/awv389. View